Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Radiofrequency Ablation versus Resection in Large Single Nodule of Hepatocellular Carcinoma: an Evidence-based Case Report

ACTA MEDICA INDONESIANA · Vol. 50 No. 4 (2019)

ISSN
2338-2732, 0125-9326
Terbit
2019-01-11
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: nowadays, radiofrequency ablation (RFA) is applied widely as an alternative therapy of resection in patient with hepatocellular carcinoma (HCC). Moreover, in single nodule with size of less than 2 cm, RFA can be the primary treatment. Although resection is the main treatment and one of the curative treatments in nodule meeting Milan criteria, it needs consideritation of the surgery risk stratification. This report was aimed to search evidence of RFA compared with RFA in term of survival in patient with HCC single nodule size of more than 5 cm. Methods: the searching was done using PubMed, Scopus, Web of Science, dan CINAHL from EBSCO with keyword of “hepatocellular carcinoma”, “single nodule”, “radiofrequency ablation”, “resection”, and “survival”. The limitation of the article was English with clinical question of “In patient with HCC single nodule size of more than 5cm, was RFA more superior in resection in term of survival?”. Results: there were three articles with retrospective study. One of the article combined RFA and percutaneous ethanol injection in the analysis, meanwhile another article combined RFA and transarterial chemoembolization. These articles showed conflicting data that showed absolute risk reduction of 33% till absolute risk increment of 60.6%. Conclusion: all studies used RFA as the alternative of resection when the the tumor was irresectable which means the severity is higher in RFA group. Hence, we can not solely conclude that RFA resulted in worse survival.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 199 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Irsan HasanAfiliasi tidak diketahui11
Rino Alvani GaniAfiliasi tidak diketahui9
Andri Sanityoso SulaimanAfiliasi tidak diketahui7
Chyntia Olivia Maurine JasirwanAfiliasi tidak diketahui7
Cosmas Rinaldi A LesmanaAfiliasi tidak diketahui6
Lutfie LutfieAfiliasi tidak diketahui4
Gita ApriliciaAfiliasi tidak diketahui4
Andri SanityosoAfiliasi tidak diketahui3
Kuntjoro HarimurtiAfiliasi tidak diketahui3
Marcellus SimadibrataAfiliasi tidak diketahui2
Siti SetiatiAfiliasi tidak diketahui2
Sally Aman NasutionAfiliasi tidak diketahui2
Evy YunihastutiAfiliasi tidak diketahui2
Ikhwan RinaldiAfiliasi tidak diketahui2
Cosmas Rinaldi Adithya LesmanaAfiliasi tidak diketahui2
Dicky Levenus TahaparyAfiliasi tidak diketahui2
Imam SubektiAfiliasi tidak diketahui2
Cleopas Martin RumendeAfiliasi tidak diketahui2
Esthika DewiastyAfiliasi tidak diketahui1
Dewi AnggraeniAfiliasi tidak diketahui1
Toar JM LalisangAfiliasi tidak diketahui1
Ening KrisnuhoniAfiliasi tidak diketahui1
Sahat MatondangAfiliasi tidak diketahui1
Abirianty P AramintaAfiliasi tidak diketahui1
Bambang SetyohadiAfiliasi tidak diketahui1
Purwita Wijaya LaksmiAfiliasi tidak diketahui1
Mienche MiencheAfiliasi tidak diketahui1
A ArianeAfiliasi tidak diketahui1
Gunawan TirtarahardjaAfiliasi tidak diketahui1
Samsuridjal DjauziAfiliasi tidak diketahui1
Rino A GaniAfiliasi tidak diketahui1
Nafrialdi NafrialdiAfiliasi tidak diketahui1
Fera IbrahimAfiliasi tidak diketahui1
Suzanna ImannuelAfiliasi tidak diketahui1
Muhadi MuhadiAfiliasi tidak diketahui1
Christopher Surya SuwitaAfiliasi tidak diketahui1
Martha RosanaAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Radiofrequency Ablation versus Resection in Large Single Nodule of Hepatocellular Carcinoma: an Evidence-based Case Report</dc:title>
	<dc:creator>Widjaja, Felix Firyanto</dc:creator>
	<dc:creator>Kalista, Kemal Fariz</dc:creator>
	<dc:creator>Kurniawan, Juferdy</dc:creator>
	<dc:subject xml:lang="en-US">hepatocellular carcinoma</dc:subject>
	<dc:subject xml:lang="en-US">radiofrequency ablation</dc:subject>
	<dc:subject xml:lang="en-US">resection</dc:subject>
	<dc:description xml:lang="en-US">Background: nowadays, radiofrequency ablation (RFA) is applied widely as an alternative therapy of resection in patient with hepatocellular carcinoma (HCC). Moreover, in single nodule with size of less than 2 cm, RFA can be the primary treatment. Although resection is the main treatment and one of the curative treatments in nodule meeting Milan criteria, it needs consideritation of the surgery risk stratification. This report was aimed to search evidence of RFA compared with RFA in term of survival in patient with HCC single nodule size of more than 5 cm. Methods: the searching was done using PubMed, Scopus, Web of Science, dan CINAHL from EBSCO with keyword of “hepatocellular carcinoma”, “single nodule”, “radiofrequency ablation”, “resection”, and “survival”. The limitation of the article was English with clinical question of “In patient with HCC single nodule size of more than 5cm, was RFA more superior in resection in term of survival?”. Results: there were three articles with retrospective study. One of the article combined RFA and percutaneous ethanol injection in the analysis, meanwhile another article combined RFA and transarterial chemoembolization. These articles showed conflicting data that showed absolute risk reduction of 33% till absolute risk increment of 60.6%. Conclusion: all studies used RFA as the alternative of resection when the the tumor was irresectable which means the severity is higher in RFA group. Hence, we can not solely conclude that RFA resulted in worse survival.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2019-01-11</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/723</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 50 No. 4 (2018): Acta Medica Indonesiana; 346</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/723/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>